Lobbying Spend
—
Filings
35
Firms Hired
1
Active Period
2019–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · third_quarter · Firm: THE NICKLES GROUP, LLC
Monitor implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 1
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair, and the ability of government contractors to pay dividends and buy back stocks.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 8800
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair, and the ability of government contractors to pay dividends and buy back stocks.
Client expense: — · Firm income: $80,000
Matched citations: S. 4784
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · second_quarter · Firm: THE NICKLES GROUP, LLC
Monitor implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 1
National Defense Authorization Act for Fiscal Year 2027
2026 · second_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair, and the ability of government contractors to pay dividends and buy back stocks.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 8800
National Defense Authorization Act for Fiscal Year 2027
2026 · second_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair, and the ability of government contractors to pay dividends and buy back stocks.
Client expense: — · Firm income: $80,000
Matched citations: S. 4784
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · first_quarter · Firm: THE NICKLES GROUP, LLC
Monitor implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
Monitor implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes.
Client expense: — · Firm income: $70,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act and pharmacy benefit management. Issues related to mental health. Issues related to SUPPORT Act Reauthorization. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Issues related to drug pricing. Issues related to ingredient safety.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: THE NICKLES GROUP, LLC
Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act and issues related to drug pricing. Issues related to Most Favored Nation drug pricing. H.R. 946 / S. 1862, ORPHAN Cures Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act and issues related to drug pricing. Issues related to Most Favored Nation drug pricing. H.R. 946 / S. 1862, ORPHAN Cures Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 946
Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act and issues related to drug pricing. Issues related to Most Favored Nation drug pricing. H.R. 946 / S. 1862, ORPHAN Cures Act.
Client expense: — · Firm income: $50,000
Matched citations: S. 1862
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 1, One Big Beautiful Bill Act and pharmacy benefit management. Issues related to mental health. Issues related to SUPPORT Act Reauthorization. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Issues related to drug pricing. Issues related to ingredient safety.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 1, One Big Beautiful Bill Act, as it relates to corporate and international taxes.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: THE NICKLES GROUP, LLC
Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1, One Big Beautiful Bill Act and issues related to drug pricing. Issues related to Most Favored Nation drug pricing. H.R. 946 / S. 1862, ORPHAN Cures Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1, One Big Beautiful Bill Act and issues related to drug pricing. Issues related to Most Favored Nation drug pricing. H.R. 946 / S. 1862, ORPHAN Cures Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 946
Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1, One Big Beautiful Bill Act and issues related to drug pricing. Issues related to Most Favored Nation drug pricing. H.R. 946 / S. 1862, ORPHAN Cures Act.
Client expense: — · Firm income: $50,000
Matched citations: S. 1862
Full-Year Continuing Appropriations and Extensions Act, 2025
2025 · first_quarter · Firm: THE NICKLES GROUP, LLC
Issues related to mental health. Issues related to SUPPORT Act reauthorization. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Monitored issues related to drug pricing. H.R. 1968 (P.L. 119-4), Full-Year Continuing Appropriations and Extensions Act, 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
2025 · first_quarter · Firm: THE NICKLES GROUP, LLC
Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1968 (P.L. 119-4), Full-Year Continuing Appropriations and Extensions Act, 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1968
American Innovation and R&D Competitiveness Act of 2025
2025 · first_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 1990, the American Innovation and R&D Competitiveness Act, and issues related to the R&D tax credit. Issues related to the extension of the 2017 Tax Cut and Jobs Act provisions, and corporate and international taxes.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1990
Full-Year Continuing Appropriations and Extensions Act, 2025
2025 · first_quarter · Firm: THE NICKLES GROUP, LLC
Issues related to mental health. Issues related to SUPPORT Act reauthorization. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Monitored issues related to drug pricing. H.R. 1968 (P.L. 119-4), Full-Year Continuing Appropriations and Extensions Act, 2025.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
2025 · first_quarter · Firm: THE NICKLES GROUP, LLC
Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1968 (P.L. 119-4), Full-Year Continuing Appropriations and Extensions Act, 2025.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1968
American Innovation and R&D Competitiveness Act of 2025
2025 · first_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 1990, the American Innovation and R&D Competitiveness Act, and issues related to the R&D tax credit. Issues related to the extension of the 2017 Tax Cut and Jobs Act provisions, and corporate and international taxes.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1990
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
2024 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. Issues related to preventative services. Issues related to pharmacy benefit management. Issues related to the Medicaid Drug Rebate Program. Monitored issues related to Medicare physician payment. H.R. 10445, Furthering Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025, as it relates to pharmacy benefit management. H.R. 10545, The American Relief Act of 2025.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 10445
Source: Senate LDA